Frazier Life Sciences

Frazier Life Sciences is a long-established healthcare investment firm focused principally on biopharmaceuticals and related life-sciences opportunities.

Official website

Healthcare and biotechnology venture capital investor
Healthcare & BioTech Venture Capital
Tier II

Overview

Frazier Life Sciences is a long-established healthcare investment firm focused principally on biopharmaceuticals and related life-sciences opportunities. It supports companies through formation, early development, clinical progress, and later private financing.

The firm combines scientific and clinical judgment with operating and capital-markets experience. Such continuity is valuable where investors must determine whether development milestones, syndicate composition, and financing reserves are sufficient to carry a program through volatile market conditions. Within The Economy Wiki, the institution is connected to the Healthcare & Biotechnology Venture Capital market category.

Firm facts

Institution	Frazier Life Sciences
Type	Healthcare and biotechnology venture capital investor
Headquarters	Seattle / Palo Alto / San Diego / Boston, United States
Founded	1991
Primary ranking focus	Healthcare & BioTech Venture Capital
Highest 2026 tier	Tier II

Contents

Activities and investment capabilities
Strategy and market coverage
Market position
Competitive context
Leadership and governance
Corporate and public information
Ranking recognition
Related Economy analysis
Related institutions and subjects
Sources

Activities and investment capabilities

Frazier Life Sciences operates within life-sciences innovation, clinical development and healthcare company building. Its category-specific capabilities are summarized below.

Life-sciences investing

Capital for therapeutics, diagnostics, medical devices and research platforms.

Clinical development

Support across scientific validation, trials, regulation and commercialization.

Healthcare innovation

Investment in care delivery, health technology and data-enabled medical businesses.

Strategy and market coverage

Stage and strategy coverage

Company formation through growth; translational research; clinical and commercial financing

Sector and market coverage

Biotechnology; therapeutics; diagnostics; medtech; digital health and healthcare services

Market position

Frazier fits Tier II because its healthcare specialization, long institutional history, company-development experience, and presence across major US life-sciences hubs make it an established specialist platform.

Frazier Life Sciences is assessed within the Healthcare & Biotechnology Venture Capital framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

Frazier Life Sciences is recognized Tier II in Top 30 Healthcare & BioTech Venture Capital 2026. The rankings compare institutions by market relevance, investment or operating capability, sector and stage expertise, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every company, fund commitment or transaction.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through the institution’s official website.

Leadership area	Current source
Investment and operating leadership	Current team and governance information

Corporate and public information

This profile refers to Frazier Life Sciences as the public-facing organization. Individual funds, management companies, advisers, lending entities, broker-dealers and regulated affiliates may use separate legal names across jurisdictions.

Corporate and disclosure information

Organization	Frazier Life Sciences
Headquarters	Seattle / Palo Alto / San Diego / Boston, United States
Public website	frazierls.com
Profile basis	Public institutional information and Capital Ranking editorial research